Cargando…
Peripheral Plasma Cells Associated with Mortality Benefit in Severe COVID-19: A Marker of Disease Resolution
BACKGROUND: Cytokines seen in severe coronavirus disease 2019 (COVID-19) are associated with proliferation, differentiation, and survival of plasma cells. Plasma cells are not routinely found in peripheral blood, though may produce virus-neutralizing antibodies in COVID-19 later in the course of an...
Autores principales: | Boulanger, Mary, Molina, Emily, Wang, Kunbo, Kickler, Thomas, Xu, Yanxun, Garibaldi, Brian T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010346/ https://www.ncbi.nlm.nih.gov/pubmed/33811876 http://dx.doi.org/10.1016/j.amjmed.2021.01.040 |
Ejemplares similares
-
Remdesivir use in severe renal impairment: benefits outweigh risks
Publicado: (2021) -
Relationship of Inflammatory Biomarkers with Severity of Peripheral Arterial Disease
por: Igari, Kimihiro, et al.
Publicado: (2016) -
Benefit of Leukocyte- and Platelet-Rich Plasma in Operative Wound Closure in Oral and Maxillofacial Surgery
por: Cieślik-Bielecka, Agata, et al.
Publicado: (2016) -
Electrochemical Skin Conductance as a Marker of Painful Oxaliplatin-Induced Peripheral Neuropathy
por: Delmotte, Jean-Baptiste, et al.
Publicado: (2018) -
KRAS mutation detection by high-resolution melting analysis significantly predicts clinical benefit of cetuximab in metastatic colorectal cancer
por: Malapelle, U, et al.
Publicado: (2012)